DNTL:TSX-dentalcorp Holdings Ltd (CAD)

COMMON STOCK | Medical Care Facilities | TSX

Last Closing Price

CAD 8.43

Change

+0.06 (+0.72)%

Market Cap

CAD 1.56B

Volume

0.22M

Avg Analyst Target

CAD 17.10 (+102.85%)

Avg User Target

CAD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


DNTL Stock Forecast & Price:
Based on the dentalcorp Holdings Ltd stock forecasts from 8 analysts, the average analyst target price for dentalcorp Holdings Ltd is CAD 17.10 over the next 12 months. dentalcorp Holdings Ltd’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of dentalcorp Holdings Ltd is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, dentalcorp Holdings Ltd’s stock price was CAD 8.43. dentalcorp Holdings Ltd’s stock price has changed by -5.92% over the past week, -21.87% over the past month and -53.14% over the last year.

About dentalcorp Holdings Ltd (DNTL:CA:TSX)

dentalcorp Holdings Ltd., through its subsidiaries, acquires and partners with dental practices to provide health care services in Canada. As of December 31, 2021, it owned and operated a network of approximately 458 dental practices supported by approximately 7,400 team members, ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-09-27 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SIA:CA Sienna Senior Living Inc

-0.19 (-1.58%)

CAD0.89B 34.91 17.14
WELL:CA WELL Health Technologies Corp

+0.07 (+2.33%)

CAD0.71B -99,999.99 17.62
EXE:CA Extendicare Inc

+0.02 (+0.30%)

CAD0.59B 83.50 9.23
DR:CA Medical Facilities Corporation

+0.35 (+3.31%)

CAD0.31B 16.76 4.40
IVQ-U:CA Invesque Inc

N/A

CAD0.16B N/A N/A
CRRX:CA CareRx Corp

-0.03 (-0.93%)

CAD0.15B N/A -64.52
GTMS:CA Greenbrook TMS Inc

+0.28 (+7.63%)

CAD0.10B N/A -11.44
DRDR:CA MCI Onehealth Technologies Inc

N/A

CAD0.08B N/A -6.53
NUMI:CA Numinus Wellness Inc

+0.01 (+4.08%)

CAD0.07B N/A -1.10
FTRP:CA Field Trip Health Ltd

N/A

CAD0.01B N/A -0.21

ETFs Containing DNTL:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -48.19% 30% F 8% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.19% 30% F 8% F
Trailing 12 Months  
Capital Gain -52.35% 50% F 7% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -52.35% 50% F 7% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.26% 40% F 9% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.26% 40% F 9% F
Risk Return Profile  
Volatility (Standard Deviation) 13.27% 100% A+ 60% D-
Risk Adjusted Return -54.72% 20% F 10% F
Market Capitalization 1.56B 100% A+ 77% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 0.91 100% A+ 65% D
Price / Cash Flow Ratio 28.25 20% F 6% F
EV/EBITDA 21.17 10% F 9% F
Management Effectiveness  
Return on Equity -4.29% 60% D- 27% F
Return on Invested Capital -3.21% 70% C- 23% F
Return on Assets -0.09% 50% F 29% F
Debt to Equity Ratio 59.06% 75% C 45% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 4.18 60% D- 43% F
Short Percent 0.82% 56% F 51% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector